Quest Partners LLC Apellis Pharmaceuticals, Inc. Transaction History
Quest Partners LLC
- $575 Billion
- Q1 2024
A detailed history of Quest Partners LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 1 shares of APLS stock, worth $36. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$36% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
335Shares Held
109MCall Options Held
1.26MPut Options Held
1.14M-
Wellington Management Group LLP Boston, MA15.1MShares$555 Million0.16% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.4MShares$419 Million19.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$410 Million7.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.51MShares$351 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$203 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.05B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...